Abstract:Objective For major depressive disorder (MDD), there has been a lack of neuroimaging markers of efficacy of pharmacological treatment. In this study, we aimed to explore the neuroimaging mechanisms in patients with first-episode MDD and identify markers that predict the efficacy of 5-hydroxytryptamine reuptake inhibitors (SSRIs) with the use of resting-state brain imaging technology. Methods A total of 101 patients with first-episode MDD and 53 normal controls were finally included in this study. Based on the reduction rate of the score of Hamilton Depression Rating Scale (HAMD-17) during the 2-week SSRI treatment, 31 patients were assigned into the unresponsive group and 32 were assigned into the responsive group. The brain function was compared between patients with MDD and normal controls, and the diagnostic value of brain function was analyzed. With brain regions showing differences between patients with MDD and normal controls as a mask, and the brain function between the responsive and unresponsive groups were compared. Correlations between brain function the HAMD-17 score reduction rate during the 2-week SSRI treatment were analyzed. Results Compared to normal controls, patients with MDD showed increased ReHo in the left parahippocampal gyrus and right parahippocampal gyrus, decreased ReHo in the right middle occipital gyrus, and decreased functional connectivity between the right and left parahippocampal gyri, right middle occipital gyrus and middle temporal gyrus. Receiver operator characteristic (ROC) curve analysis showed that the area under the curve (AUC) was 0.544 (95% CI: 0.445–0.644) for ReHo and 0.822 (95% CI: 0.734–0.909) for functional connectivity. Logistic regression pooling of the differences in ReHo mean time series with the functional connectivity mean time series was performed for the ROC curve analysis, which showed an AUC of 0.832 (95% CI: 0.752–0.911). Compared to the responsive group, the unresponsive group showed elevated ReHo in the right parahippocampal gyrus and lower functional connectivity in the middle temporal gyrus. We also found that the ReHo value was negatively correlated with the HAMD-17 score reduction after 2 weeks of SSRI treatment. Conclusion Altered resting-state brain function in some regions might be a neurobiological marker for the diagnosis of MDD, and ReHo values are expected to be predictors of patient response to treatment with SSRIs. Clinical Trial Registration [ http://www.chictr.org.cn/ ], identifier [ChiCTR1900028722].

Increased Temporal Variability of Striatum Region Facilitating the Early Antidepressant Response in Patients with Major Depressive Disorder

Predict Value of Functional Topological Features for Early Response to Antidepressant Treatment in Major Depressive Disorder

Sub-hubs of Baseline Functional Brain Networks Are Related to Early Improvement Following Two-Week Pharmacological Therapy for Major Depressive Disorder.

Pretreatment predictors of early response revealed by quantitative cerebral blood flow in major depressive disorder

Divergent Topological Architecture of the Default Mode Network As a Pretreatment Predictor of Early Antidepressant Response in Major Depressive Disorder

Distinct Features of Cerebral Blood Flow and Spontaneous Neural Activity as Integrated Predictors of Early Response to Antidepressants.

Distinctive Pretreatment Features of Bilateral Nucleus Accumbens Networks Predict Early Response to Antidepressants in Major Depressive Disorder

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder

Prognostic value of imbalanced interhemispheric functional coordination in early therapeutic efficacy in major depressive disorder

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

Local and large-scale resting-state oscillatory dysfunctions for early antidepressant response prediction in major depressive disorder

Amplitude of Low Frequency Fluctuation in First-onset Major Depressive Disorder by Antidepressant Treatment Investigated with Resting-state Functional MRI

Electrophysiological predictors of early response to antidepressants in major depressive disorder

Classification of Major Depressive Disorder Based on Integrated Temporal and Spatial Functional MRI Variability Features of Dynamic Brain Network

Association Analysis of Imbalanced Interhemispheric Functional Coordination and Early Therapeutic Efficacy in Major Depressive Disorder: Evidence from Resting State Fmri

In perspective of specific symptoms of major depressive disorder: Functional connectivity analysis of electroencephalography and potential biomarkers of treatment response

More Than Just Statics: Temporal Dynamic Changes in Inter- and Intrahemispheric Functional Connectivity in First-Episode, Drug-Naive Patients With Major Depressive Disorder

Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug‐Naïve Patients with Major Depressive Disorder

Longitudinal changes of amplitude of low-frequency fluctuations in MDD patients: A 6-month follow-up resting-state functional magnetic resonance imaging study

Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study